Discovery and Pharmacological Study of a Novel GPR142 Antagonist, CLP-3094 and a Metal Modulator, Zn ion

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery and pharmacological effects of a novel GPR142 antagonist

  2017cited by this paper
• The electrodialysis of electrolyte solutions of multi-charged cations

  2016cited by this paper
• Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP+ and Rotenone Toxicity

  2016cited by this paper
• GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids l-Tryptophan and l-Phenylalanine

  2015cited by this paper
• The role of serotonin and its receptors in activation of immune responses and inflammation

  2015cited by this paper
• Identification of metals from osteoblastic ST-2 cell supernatants as novel OGR1 agonists

  2015cited by this paper
• High-throughput screening of antagonists for the orphan G-protein coupled receptor GPR139

  2015cited by this paper
• Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case–control study

  2015cited by this paper
• Interleukin (IL)-17A, F and AF in inflammation: a study in collagen-induced arthritis and rheumatoid arthritis

  2014cited by this paper
• Kynurenines in CNS disease: regulation by inflammatory cytokines

  2014cited by this paper
• G-Protein Coupled Receptor 83 (GPR83) Signaling Determined by Constitutive and Zinc(II)-Induced Activity

  2013cited by this paper
• Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering

  2012cited by this paper
• IL-17-deficient allogeneic bone marrow transplantation prevents the induction of collagen-induced arthritis in DBA/1J mice

  2012cited by this paper
• Inflammation and Bone Destruction in Arthritis: Synergistic Activity of Immune and Mesenchymal Cells in Joints

  2012cited by this paper
• Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus.

  2012cited by this paper
• [Animal models for bone and joint disease. CIA, CAIA model].

  2011cited by this paper
• [Animal models for bone and joint disease. The genetically-modified mice as a tool for osteoporosis research].

  2011cited by this paper
• Assessment of Zinc Concentration in Random Samples of the Adult Population in Shiraz, Iran

  2011cited by this paper
• Serum Levels of Tryptophan, 5-Hydroxytryptophan and Serotonin in Patients Affected with Different Forms of Amenorrhea

  2010cited by this paper
• Golimumab: A Tumor Necrosis Factor Alpha Inhibitor for the Treatment of Rheumatoid Arthritis

  2010cited by this paper
• Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.

  2009cited by this paper
• Identification of Surrogate Agonists and Antagonists for Orphan G-Protein-Coupled Receptor GPR139

  2009cited by this paper
• The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm.

  2009cited by this paper
• Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial

  2009cited by this paper
• An ion-responsive motif in the second transmembrane segment of rhodopsin-like receptors

  2008cited by this paper
• Orphan GPCR research

  2008cited by this paper
• GPR39 signaling is stimulated by zinc ions but not by obestatin.

  2007cited by this paper
• Drug evaluation: apilimod, an oral IL-12/IL-23 inhibitor for the treatment of autoimmune diseases and common variable immunodeficiency.

  2007cited by this paper
• Collagen antibody induced arthritis.

  2007cited by this paper
• Characterisation and differential expression of two very closely related G-protein-coupled receptors, GPR139 and GPR142, in mouse tissue and during mouse development.

  2006cited by this paper
• Role of metal ions in ligand-receptor interaction: insights from structural studies.

  2006cited by this paper
• Calcium Signaling Protocols

  2005cited by this paper
• Molecular cloning and characterization of a novel Gq-coupled orphan receptor GPRg1 exclusively expressed in the central nervous system.

  2005cited by this paper
• Mammalian G proteins and their cell type specific functions.

  2005cited by this paper
• Reverse pharmacology and the de-orphanization of 7TM receptors.

  2004cited by this paper
• Desensitization of G protein-coupled receptors and neuronal functions.

  2004cited by this paper
• Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells

  2004cited by this paper
• Scintillation proximity assay of inositol phosphates in cell extracts: high-throughput measurement of G-protein-coupled receptor activation.

  2003cited by this paper
• Correlation of single time-point damage scores with observed progression of radiographic damage during the first 6 years of rheumatoid arthritis.

  2003cited by this paper
• Seven evolutionarily conserved human rhodopsin G protein‐coupled receptors lacking close relatives

  2003cited by this paper
• Tryptophan and the immune response

  2003cited by this paper
• Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes.

  2003cited by this paper
• The G protein-coupled receptor repertoires of human and mouse

  2003cited by this paper
• The druggable genome

  2002cited by this paper
• Allosteric Modulation of β2-Adrenergic Receptor by Zn2+

  2002cited by this paper
• High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.

  2002cited by this paper
• The Importance of IL-1β and TNF-α, and the Noninvolvement of IL-6, in the Development of Monoclonal Antibody-Induced Arthritis

  2002cited by this paper
• Mouse models for rheumatoid arthritis

  2002cited by this paper
• Identification and characterization of a melanin-concentrating hormone receptor

  2001cited by this paper
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

  1999cited by this paper
• An HPLC method to determine tryptophan and kynurenine in serum simultaneously.

  1999cited by this paper
• Potential interactions of zinc in the neuroendocrine-endocrine disturbances of diabetes mellitus type 2.

  1999cited by this paper
• Ghrelin is a growth-hormone-releasing acylated peptide from stomach

  1999cited by this paper
• Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis.

  1998cited by this paper
• Zinc, insulin and diabetes.

  1998cited by this paper
• Effects of germinated barley foodstuff on dextran sulfate sodium-induced colitis in rats

  1998cited by this paper
• The orphan opioid receptor and its endogenous ligand--nociceptin/orphanin FQ.

  1997cited by this paper
• Complexity and diversity of mammalian adenylyl cyclases.

  1996cited by this paper
• Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins.

  1996cited by this paper
• Signaling by the G12 class of G proteins.

  1996cited by this paper
• Influence of gold salts treatment on the serum concentration of IL-1 and IL-2 in patients with rheumatoid arthritis.

  1995cited by this paper
• Inverse agonism: pharmacological curiosity or potential therapeutic strategy?

  1995cited by this paper
• Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen.

  1995cited by this paper
• G alpha 12 and G alpha 13 stimulate Rho-dependent stress fiber formation and focal adhesion assembly.

  1995cited by this paper
• High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype.

  1994cited by this paper
• Specificity of antibodies to type II collagen in early rheumatoid arthritis.

  1994cited by this paper
• Induction of arthritis with monoclonal antibodies to collagen.

  1992cited by this paper
• Current developments in G-protein-coupled receptors.

  1991cited by this paper
• Selective amplification and cloning of four new members of the G protein-coupled receptor family.

  1989cited by this paper
• Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG

  1985cited by this paper
• Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4

  1985cited by this paper
• Clinical Pharmacology of Tolmetin: Comparisons in Rheumatoid Arthritis Patients and Normal Volunteers

  1983cited by this paper
• [Rheumatoid arthritis].

  1983cited by this paper
• Continuous production of monoclonal rheumatoid factor by EBV-transformed lymphocytes

  1980cited by this paper

• No citing papers are available for this paper.